Theobald, M; Voss, RH
T-Zell-Rezeptor-TransferHuber C, Rammensee H-G, Wölfel T, Britten CM (Hrsg). Krebsimmuntherapien. Deutscher Ärzte-Verlag 2008
Hahnel, PS; Thaler, S; Antunes, E et al.
Targeting AKT signaling sensitizes cancer to cellular immunotherapy.Cancer Res. Bd. 68. H. 10. 2008 S. 3899-906
Stolz, C; Hess, G; Hahnel, PS et al.
Targeting Bcl-2 family proteins modulates the sensitivity of B-cell lymphoma to rituximab-induced apoptosis.Blood. Bd. 112. H. 8. 2008 S. 3312-21
Britten, CM; Gouttefangeas, C; Welters, MJ et al.
The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays.Cancer Immunol Immunother. Bd. 57. H. 3. 2008 S. 289-302
von Haussen, J; Koczulla, R; Shaykhiev, R et al.
The host defence peptide LL-37/hCAP-18 is a growth factor for lung cancer cells.Lung Cancer. Bd. 59. H. 1. 2008 S. 12-23
Kasper, S; Breitenbuecher, F; Hoehn, Y et al.
The kinase inhibitor LS104 induces apoptosis, enhances cytotoxic effects of chemotherapeutic drugs and is targeting the receptor tyrosine kinase FLT3 in acute myeloid leukemia.Leuk Res. Bd. 32. H. 11. 2008 S. 1698-708
Wiewroth, D; Kern, T; Fischbeck, S
The need for psychosocial intervention in relartives of glioma patientsOnkologie. Bd. 31. 2008 S. 163
Schuchmann, M; Meyer, RG; Distler, E et al.
The programmed death (PD)-1/PD-ligand 1 pathway regulates graft-versus-host-reactive CD8 T cells after liver transplantationAm J Transplant. Bd. 8. H. 11. 2008 S. 2434-44
Hunzelmann, N; Genth, E; Krieg, T et al.
The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement.Rheumatology (Oxford). Bd. 47. H. 8. 2008 S. 1185-92
Taube, C; Buhl, R
Therapie des Asthma bronchiale: Wie gut sind wir wirklich?Der Pneumologe. Bd. 5. 2008 S. 24-31